Vaxcyte Inc.
PCVX | NASDAQ
$59.28
+$0.36 (+0.61%)
Sep 22, 2026, 11:32 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.38B | -946.53M | -766.63M | -657.2M | -547.5M | -509.63M | -463.93M | -507.65M | -497.19M | -436.82M | -402.27M | -299.52M | -264.77M | -244.96M | -223.49M | -174M | -142.7M | -117.84M | -100.08M | -92.25M | -86.65M | -83.3M |
Depreciation & Amortization | 26.8M | 25.84M | 24.86M | 19.85M | 19.14M | 17.63M | 15.85M | 14.01M | 12M | 10.92M | 10.17M | 9.52M | 9.4M | 9.17M | 9.2M | 8.1M | 6.6M | 5.3M | 3.46M | 2.58M | 2.06M | 1.55M |
Stock-Based Compensation | 188.47M | 146.19M | 138.85M | 127.22M | 113.18M | 97.81M | 84.82M | 73.8M | 65.76M | 56.74M | 48.76M | 42.42M | 35.85M | 29.2M | 23.65M | 19.8M | 16.09M | 12.96M | 10.73M | 9.51M | 8.41M | 6.93M |
Other Working Capital | -71.26M | 17.71M | n/a | -15.78M | -9.08M | -30.33M | -89.48M | -24.1M | -11.71M | -14.39M | 70.1M | 31.74M | 10.4M | 8.5M | 9.84M | 7.23M | -12.28M | -21.5M | -24.54M | -26.22M | -21.03M | -842K |
Other Non-Cash Items | 8.46M | -61.94M | -72.56M | -45.77M | -55.28M | -35.01M | -34.47M | -35.85M | -37.87M | -39.78M | -34.78M | -25.59M | -11.25M | 893K | 7.31M | 1.05M | 1.75M | 1.77M | 1.5M | 944K | 499K | 452K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -702K | 66.51M | 19.91M | 13.77M | 10.91M | -30.58M | -54.9M | -14.35M | -9.57M | 715K | 81.32M | 39.96M | 16.57M | 15.12M | 12.74M | -11.42M | -28.08M | -38.08M | -37.01M | -1.85M | 9.98M | 28.17M |
Operating Cash Flow | -1.16B | -769.93M | -655.58M | -542.15M | -459.55M | -459.78M | -452.63M | -470.04M | -466.88M | -408.22M | -296.79M | -233.2M | -214.2M | -190.59M | -170.6M | -156.47M | -146.34M | -135.89M | -121.39M | -81.07M | -65.71M | -46.2M |
Capital Expenditures | -40.64M | -1.76M | -13.71M | -49.31M | -75.34M | -140.23M | -125.55M | -152.6M | -121.85M | -74.34M | -67.88M | -11.96M | -5.46M | -8.54M | -5.85M | -6.08M | -6.96M | -8.23M | -6.56M | -5.9M | -4.21M | -2.05M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -29.62K | 306.09K | 748.58K | 783.38K | 777.45K | 414.65K | -27.85K | -62.65K | -27.1K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.98B | -1.48B | -1.21B | -1.73B | -2.71B | -2.71B | -3.09B | -2.48B | -1.45B | -1.53B | -1.33B | -1.2B | -1.01B | -579.55M | -102.75M | -72.52M | -121.68M | -171.17M | -336.34M | -295.28M | -228.53M | -172.15M |
Sales Maturities Of Investments | 1.96B | 1.61B | 1.71B | 1.58B | 1.54B | 1.42B | 1.2B | 1.16B | 1.04B | 831.87M | 624.46M | 414.19M | 228.04M | 164.91M | 183.17M | 189.19M | 186.05M | 190.11M | 130.56M | 88.06M | 38.06M | n/a |
Other Investing Acitivies | -13.99M | -43.26M | -43.26M | -29.27M | -29.27M | 6.39M | 6.39M | 6.39M | 6.42M | -306.09K | -748.58K | -783.38K | -777.45K | -414.65K | 34.85K | 95.65K | 60.1K | 33K | 26K | n/a | 50K | 50K |
Investing Cash Flow | -82.81M | 80.63M | 437.35M | -234.94M | -1.27B | -1.43B | -2.01B | -1.46B | -523.13M | -776.28M | -773.31M | -795.34M | -782.91M | -423.18M | 74.59M | 110.62M | 57.44M | 10.75M | -212.31M | -213.11M | -194.62M | -174.15M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -18.68M | -8.04M | -4.04M | -5.09M | 1.29M | 5.84M | 12.85M | 10.71M | 7.86M | 5.71M | 3.77M | 4.03M | 5.37M | 4.56M | 5.07M | 4.02M | 3.61M | 2.74M | 2.46M | 1.05M | 591K | 265.07M |
Financial Cash Flow | 1.21B | 602.84M | 2.01M | 4.51M | 1.52B | 1.63B | 2.45B | 2.45B | 979.85M | 1.42B | 639.81M | 1.29B | 1.29B | 792.09M | 861.55M | 213.67M | 177.25M | 128.33M | 17.8M | 9.6M | 2.03M | 265.56M |
Net Cash Flow | -36.52M | -85.86M | -213.77M | -768.96M | -211.71M | -264.45M | -9.36M | 505.27M | -12.13M | 231.29M | -436.97M | 266.97M | 292.86M | 178.71M | 765.67M | 166.36M | 87.18M | 2.8M | -316.34M | -284.13M | -258.18M | 45.02M |
Free Cash Flow | -1.2B | -771.68M | -669.29M | -591.45M | -534.89M | -600.01M | -578.18M | -622.63M | -588.73M | -482.56M | -364.67M | -245.16M | -219.66M | -199.12M | -176.45M | -162.55M | -153.3M | -144.12M | -127.95M | -86.96M | -69.91M | -48.25M |
Adj. Free Cash Flow | -1.39B | -917.88M | -808.14M | -718.67M | -648.07M | -697.82M | -663M | -696.43M | -654.49M | -539.31M | -413.43M | -287.58M | -255.51M | -228.32M | -200.1M | -182.35M | -169.38M | -157.08M | -138.68M | -96.47M | -78.32M | -55.18M |
Maintenance CapEx | -22.57M | -21.61M | -20.63M | -19.85M | -19.14M | -17.63M | -15.85M | -14.01M | -12M | -10.66M | -9.91M | -8.11M | -6.47M | -5.27M | -5.3M | -5.36M | -5.37M | -5.3M | -3.46M | -2.58M | -1.76M | -943K |
Growth CapEx | -18.07M | 19.85M | 6.92M | -29.46M | -56.2M | -122.6M | -109.71M | -138.59M | -109.86M | -63.68M | -57.97M | -3.85M | 1.01M | -3.27M | -551K | -727K | -1.59M | -2.93M | -3.1M | -3.31M | -2.45M | -1.11M |
Owner Earnings | -1.18B | -791.54M | -676.21M | -561.99M | -478.69M | -477.41M | -468.47M | -484.04M | -478.87M | -418.88M | -306.7M | -241.31M | -220.67M | -195.86M | -175.89M | -161.83M | -151.71M | -141.19M | -124.85M | -83.65M | -67.46M | -47.14M |
Add to Watchlist
Select watchlists to add or remove PCVX